- Home
- TWIN vs INBX Comparison
TWIN vs INBX Comparison
Compare TWIN & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWIN
- INBX
- Stock Information
- Founded
- TWIN 1918
- INBX 2010
- Country
- TWIN United States
- INBX United States
- Employees
- TWIN N/A
- INBX N/A
- Industry
- TWIN Industrial Machinery/Components
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- TWIN Industrials
- INBX Health Care
- Exchange
- TWIN Nasdaq
- INBX Nasdaq
- Market Cap
- TWIN 186.2M
- INBX 430.2M
- IPO Year
- TWIN N/A
- INBX 2020
- Fundamental
- Price
- TWIN $14.39
- INBX $36.60
- Analyst Decision
- TWIN Strong Buy
- INBX Hold
- Analyst Count
- TWIN 1
- INBX 2
- Target Price
- TWIN $12.00
- INBX N/A
- AVG Volume (30 Days)
- TWIN 37.0K
- INBX 164.8K
- Earning Date
- TWIN 11-05-2025
- INBX 11-13-2025
- Dividend Yield
- TWIN 1.12%
- INBX N/A
- EPS Growth
- TWIN N/A
- INBX N/A
- EPS
- TWIN N/A
- INBX N/A
- Revenue
- TWIN $340,738,000.00
- INBX $1,400,000.00
- Revenue This Year
- TWIN $10.79
- INBX $563.00
- Revenue Next Year
- TWIN $8.43
- INBX $230.77
- P/E Ratio
- TWIN N/A
- INBX N/A
- Revenue Growth
- TWIN 15.46
- INBX N/A
- 52 Week Low
- TWIN $6.16
- INBX $10.81
- 52 Week High
- TWIN $15.12
- INBX $37.53
- Technical
- Relative Strength Index (RSI)
- TWIN 57.70
- INBX 69.06
- Support Level
- TWIN $14.11
- INBX $31.28
- Resistance Level
- TWIN $15.00
- INBX $35.96
- Average True Range (ATR)
- TWIN 0.63
- INBX 2.19
- MACD
- TWIN -0.07
- INBX -0.08
- Stochastic Oscillator
- TWIN 58.08
- INBX 85.03
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.